FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology and can be applied in presence of locally advanced process. In daily urine of patients before treatment tetrahydro-11-desoxycortisol is determined. If its level before treatment does not exceed 2 mcmol/day relapse-free period is forecasted during 2 and more years; initial level of fraction over 2 mcmol/day indicates about disease relapse or metastases during first year after treatment.
EFFECT: technical-economical efficiency of method consists in possibility to forecast disease relapse or metastases; individualise medicinal influences in earlier terms.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF FORECASTING RETROCESSIONS OF LARYNX CANCER | 2008 |
|
RU2389030C1 |
| METHOD OF DETERMINING EFFICIENCY OF TREATMENT OF UTERINE BODY CANCER | 2010 |
|
RU2424806C1 |
| METHOD FOR PREDICTION OF DURATION OF RECURRENCE-FREE INTERVAL IN PATIENTS WITH RECTAL CANCER | 2009 |
|
RU2415429C1 |
| METHOD FOR TREATING CANCER | 2004 |
|
RU2271223C2 |
| METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH MAMMARY CANCER | 2003 |
|
RU2251692C2 |
| METHOD FOR PREDICTING RECURRENT DISEASE | 2010 |
|
RU2471191C2 |
| METHOD OF TREATING STOMACH CANCER | 2010 |
|
RU2471512C2 |
| METHOD FOR CANCER TREATMENT | 2003 |
|
RU2255738C2 |
| METHOD OF PREDICTION OF RECURRENT VULVAR CANCER I AND II STAGE | 2015 |
|
RU2608508C1 |
| METHOD FOR SPECIFYING DIRECTIONALITY OF PATHOLOGICAL PROCESS IN MUCINOUS GASTRIC CARCINOMA | 2012 |
|
RU2480771C1 |
